FDA Inspection
Apotex Pharmachem India Pvt Ltd.Apotex Pharmachem India Pvt Ltd. – FDA Inspection, Mar 14, 2025
Record Details
This FDA Inspection record concerns Apotex Pharmachem India Pvt Ltd., with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 078f033c-9d6c-4ad0-bc20-f801f4b2a37d
Inspection Facts
- Inspection number
- 1263710
- FDA center
- Human Drugs
Other FDA inspections of Apotex Pharmachem India Pvt Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 2, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 3, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apotex Pharmachem India Pvt Ltd.
- FDA Inspection 1180313 - 2022-09-02
- FDA Inspection 1118806 - 2020-01-31
- FDA Inspection 1057873 - 2018-06-26
- FDA Inspection 978926 - 2016-06-03
- FDA Inspection 868946 - 2014-01-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.